Glucovation Inc, based in Carlsbad, CA, is a pioneering company dedicated to developing and advancing wearable glucose sensor technology. Their continuous glucose monitoring (CGM) system offers a painless, easy-to-use, and highly accurate solution for individuals managing diabetes, providing valuable data every 5 minutes over the sensor's lifespan. With the aim of accelerating the adoption of CGM, Glucovation's world-class device has the potential to revolutionize diabetes management and contribute to the development of a true artificial pancreas.
Founded in 2013, Glucovation has conducted extensive research, filed patents, and completed initial clinical trials to create a novel and superior CGM system. Recognizing the global epidemic of diabetes, the company's mission is to provide patients and physicians with comprehensive data to effectively manage the condition. By correlating CGM data with other variables such as diet and exercise, Glucovation aims to potentially reverse the disease in pre-diabetics and non-insulin dependent Type II diabetics. With the global CGM market expected to grow, Glucovation is at the forefront of advancing this essential technology for the benefit of millions affected by diabetes worldwide.
Generated from the website